BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 15803642)

  • 1. [Complication after implantable cardioverter defibrillator implantation: report of 1 case].
    Lou ZY; Zhou MH; Li XQ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Mar; 25(3):360. PubMed ID: 15803642
    [No Abstract]   [Full Text] [Related]  

  • 2. Implantable cardioverter/defibrillators (ICDs).
    Med Lett Drugs Ther; 1994 Sep; 36(932):86-8. PubMed ID: 8084305
    [No Abstract]   [Full Text] [Related]  

  • 3. Superior vena cava syndrome and syncope in an implantable cardioverter defibrillator recipient.
    Kostopoulou A; Sbarouni E; Livanis EG; Theodorakis GN; Kremastinos D
    Europace; 2004 May; 6(3):205-8. PubMed ID: 15121071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Guidelines for cardioverter defibrillator implantation].
    Andrade JC; Avila Neto V; Braile DM; Brofman PR; Costa AR; Costa R; Galvão Filho SS; Gauch PR; Lucchese FA; Martinelli Filho M; Medeiros PT; Mateos JC; Pimenta J; Takeda RT
    Arq Bras Cardiol; 2000 May; 74(5):481-2. PubMed ID: 10951840
    [No Abstract]   [Full Text] [Related]  

  • 5. Inappropriate implantable cardioverter-defibrillator therapy: many causes and many possible solutions.
    Zareba W
    Cardiol J; 2009; 16(5):391-3. PubMed ID: 19753515
    [No Abstract]   [Full Text] [Related]  

  • 6. [Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone].
    Della Bella P
    Ital Heart J Suppl; 2000 Aug; 1(8):1070-1. PubMed ID: 10993020
    [No Abstract]   [Full Text] [Related]  

  • 7. Inappropriate implantable cardioverter-defibrillator shock due to external alternating current leak: report of two cases.
    Chan NY; Wai-Ling Ho L
    Europace; 2005 Mar; 7(2):193-6. PubMed ID: 15763537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal outcome from inappropriate defibrillation.
    Dimitri H; John B; Young GD; Sanders P
    Europace; 2007 Nov; 9(11):1059-60. PubMed ID: 17827163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Near-fatal incident on routine induction of ventricular fibrillation at the replacement of an implantable cardioverter defibrillator.
    Kolb C; Zrenner B; Schmitt C
    Int J Cardiol; 2006 Oct; 112(3):e74-5. PubMed ID: 16859778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Food for afterthought: reflections from 2 implantable cardioverter defibrillator trials.
    Rahimtoola SH
    Arch Intern Med; 2004 Sep; 164(17):1835-9. PubMed ID: 15451756
    [No Abstract]   [Full Text] [Related]  

  • 11. Can incremental innovation of implantable cardioverter-defibrillator systems become disruptive to patient care? Moore's law gone awry.
    Naccarelli GV
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):621-2. PubMed ID: 16836710
    [No Abstract]   [Full Text] [Related]  

  • 12. Lead system causing twiddler's syndrome in patients with an implantable cardioverter-defibrillator.
    Bracke F; van Gelder B; Dijkman B; Meijer A
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):231-2. PubMed ID: 15632856
    [No Abstract]   [Full Text] [Related]  

  • 13. Non-determinable defibrillation threshold and inefficacy of implantable cardioverter/defibrillator shocks due to defective connections of the defibrillator lead terminals in the device header port.
    Maagh P; Trappe HJ; Meissner A
    Europace; 2007 Dec; 9(12):1161-2. PubMed ID: 17913694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stabilizing and resuscitating patients with automatic implantable cardioverter-defibrillators.
    Ellis JI
    West J Med; 1993 Nov; 159(5):595-6. PubMed ID: 8279158
    [No Abstract]   [Full Text] [Related]  

  • 15. A case of exhaustion of implantable cardioverter defibrillator therapies due to inappropriate programming.
    Fragakis NK; Antoniadis AP; Geleris P
    Hellenic J Cardiol; 2011; 52(4):354-6. PubMed ID: 21933768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous implantable cardioverter-defibrillator lead erosion after weight loss.
    Pai RK; Cadman CS
    Cardiol Rev; 2005; 13(1):27. PubMed ID: 15596025
    [No Abstract]   [Full Text] [Related]  

  • 17. Chapter 10. Current evidence on the cost effectiveness of the implantable cardioverter defibrillator.
    O'Brien BJ; Yee R
    Can J Cardiol; 2000 Jun; 16 Suppl C():45C-7C. PubMed ID: 10887279
    [No Abstract]   [Full Text] [Related]  

  • 18. Phantom shock in a patient with an implantable cardioverter defibrillator: case report.
    Prudente LA
    Am J Crit Care; 2003 Mar; 12(2):144-6. PubMed ID: 12625172
    [No Abstract]   [Full Text] [Related]  

  • 19. Failure of an implantable cardioverter defibrillator to terminate ventricular tachycardia: why?
    Conti L; Tran N; Burri H; Zimmermann M
    Pacing Clin Electrophysiol; 2010 Feb; 33(2):228-30. PubMed ID: 19821932
    [No Abstract]   [Full Text] [Related]  

  • 20. Inappropriate therapy and fatal proarrhythmia by an implantable cardioverter-defibrillator.
    Vollmann D; Lüthje L; Vonhof S; Unterberg C
    Heart Rhythm; 2005 Mar; 2(3):307-9. PubMed ID: 15851324
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.